-
MEXIDOL® (Emoxipine) 125 mg, 50 coated tablets
$17.00
$22.00 -
ARPEFLU (Umifenovir) 100 mg, 20/30 caps
$24.00 – $33.00
Prosteks 10 mg 10s lyophilisates for solution for injection in ampoules
$37.00
Description
The instruction for medical use of Prostex Torgovoye medicine a name of Prostex the International unlicensed name Is not present the Dosage form Lyophilisate for preparation of solution for injections, Structure One bottle active agent – the extract of a prostate of bulls lyophilized from aqueous solution received by extraction of 10 mg, excipient – glycine of 20 mg contains 10 mg. Description Amorphous powder or porous mass of color, white or white with yellow shade. Pharmacotherapeutic group Drugs for treatment of urological diseases. Drugs for treatment of a benign hypertrophy of a prostate. Other drugs for treatment of a benign hypertrophy of a prostate. The ATX G04CX code the Pharmacological Pharmacokinetics As properties peptide drug, Prostex is split by cellular proteases to amino acids. Prostex and its metabolites are excreted with urine. Drug has no cumulative action. The pharmacodynamics of Prostex possesses specific organotropic action on a prostate. In prostate diseases, drug as means of pathogenetic therapy normalizes processes of microcirculation and a platelet and vascular hemostasis, reduces and eliminates fabric hypostases, leukocytic infiltration (including lowers the maintenance of leukocytes in secretion of gland), shows the mediated bacteriostatic influence concerning secret microflora, reduces a caption of the revealed activator up to absolute sterility or activity of microorganisms oppresses. Prostex normalizes a spermatogenesis (increases quantity and mobility of spermatozoa), has the modulating impact on a condition of T – and V-lymphocytes, regulates a tone of muscles of a bladder, including a detruzor tone, increases nonspecific resistance of an organism. Indications – chronic prostatitis, prostate adenoma – a benign hyperplasia of a prostate – a complication after operations on a prostate – age disturbances of functions of a prostate – sexual disorders (copulative dysfunctions, male infertility) the Route of administration and doses use Drug for treatment of adult men, including advanced age. Prostex enter intramusculary. Contents of a bottle are dissolved by ex tempore in 1-2 ml of water for injections or isotonic solution of sodium of chloride, or 0.5% of solution of novocaine (at dissolution in novocaine it is necessary to consider a possibility of hypersensitivity to it). When using novocaine as solvent it is necessary to consider information on safety of novocaine. The drug is administered daily once a day on 1-2 bottles. The course of treatment makes 5-10 days. Duration of a course is defined by the character and severity of a disease reached by therapeutic effect, the nature of therapy. According to indications repeated courses are possible (in 1-6 months). Side effects Seldom – allergic reactions, including an itching, rash, changes in the injection site of the Contraindication – individual hypersensitivity to medicines of the peptide nature, proteins of cattle – children’s and teenage age up to 18 years Medicinal interactions are not recommended to be used with drugs which cause allergic reactions. Drug should not be mixed with other medicines in one syringe. To use only the recommended solvent. At drug treatment the analysis of clinical indications of activity of a prostate (prostatospetsifichny antigen) is recommended to carry out special instructions. Features of influence of medicine on ability to run the vehicle and potentially dangerous to the mekhanizmamena are studied. Overdose the Expressed symptoms of side effect, increase in level of allergic reactions is possible. A form of release and packing On 30 mg of drug in the glass bottles of 2 ml corked by traffic jams brombutilovy rubber for freeze drying, which are pressed out by caps aluminum. On bottles paste the label on the sticky basis. On 5 bottles put in blister strip packaging from a PVC film which becomes covered with aluminum foil. On the 2nd blister strip packagings together with the instruction for medical use in the state and Russian languages place in a pack from the worker’s cardboard. Packs put in a group container and paste the label group. A group and transport container according to GOST 17768-90. To Store storage conditions in original packing for protection against light at a temperature not above 25 °C. To store out of children’s reach! 3 years not to use a period of storage after the expiration date specified on packing. Prescription status According to the prescription the Producer/packer of LLC Federal Law BIOFARMA, Ukraine 09100, Kiev Region, Bila Tserkva, Kiyevskaya St., 37 ph. (044) 277-36-10 The owner of the registration certificate of LLC Federal Law BIOFARMA, Ukraine the Address of the organization accepting in the territory of the Republic of Kazakhstan claims from consumers on quality of products and responsible for post-registration observation of safety of medicine Representative office of LLC Federal Law BIOFARMA in RK of Almaty, Miras 65, BC Miras, office 101
Reviews
There are no reviews yet.